Eliminating periodontal infection in patients with type 2 diabetes
Not Applicable
Completed
- Conditions
- Topic: Diabetes Research Network, Oral and Gastrointestinal, Primary Care Research Network for EnglandSubtopic: Type 2, Oral and Gastrointestinal (all Subtopics)Disease: Other, Oral & DentalOral HealthPeriodontal infection
- Registration Number
- ISRCTN57210949
- Lead Sponsor
- ewcastle upon Tyne Hospitals NHS Foundation Trust (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 160
Inclusion Criteria
Not provided at time of registration
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> 1. Serum HbA1c, lipid profile, high sensitivity C-reactive protein (hsCRP)<br> 2. Inflammatory cytokines (IL-1b, TNF-a, IL-6, INF-y)<br>
- Secondary Outcome Measures
Name Time Method ot provided at time of registration
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link periodontal infection to type 2 diabetes progression in ISRCTN57210949?
How does periodontal treatment in type 2 diabetes patients compare to standard-of-care in clinical outcomes?
Which biomarkers correlate with improved glycemic control after periodontal intervention in diabetes?
What adverse events are associated with periodontal therapy in type 2 diabetes patients?
Are there combination therapies with periodontal treatment for type 2 diabetes management?